Navigation Links
Mendel Biotechnology to sell its subsidiary, Mendel Plant Sciences
Date:9/4/2013

HAYWARD, Calif., Sept. 4, 2013 /PRNewswire/ -- Mendel Biotechnology Inc. ("MBI"), a leading agricultural discovery company, is announcing its intention to sell its operating subsidiary, Mendel Plant Sciences ("Mendel" or "the Company"). Mendel Biotechnology Inc. will continue to operate its royalty-based, biotech trait business developed primarily in collaboration with Monsanto. The separation of the two distinct businesses will enable each to maximize their respective value.

Mendel's knowledge of the 'Plant Gene Regulatory Networks', that control crop productivity processes, is a direct result of more than $100 million invested in research and development. This investment in people and facilities has generated advanced technologies, including Mendel's Productivity Reporter Panel, a proprietary screening system, new biotech traits and novel herbicide candidates.  Mendel has discovered performance chemistries and biostimulants that enhance crop productivity through improved drought tolerance, water use, disease resistance and photosynthesis. 

Neal Gutterson, President and CEO of MBI, said: "We have made tremendous progress at Mendel, generating new technologies for improving plant growth and performance through both seed and agrochemical products. We believe that our technologies can help shape the future of the agricultural industry".

MBI has engaged Kirchner Group, a leading mid-market M&A firm with expertise in the agriculture and food industries, to advise the Board and lead the acquisition process.  "The Board of Directors feels that the Company can best achieve its full potential within the context of a larger organization that has a complementary strategic focus.  In this way, it could fully realize its commercial opportunities within the billion-dollar markets that its platform creates," explained Gutterson. Interested parties should contact
'/>"/>

SOURCE Mendel Biotechnology Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water Use Efficiency and Photosynthesis in Corn
2. Quantason Names Dr. Ellen B. Mendelson, Medical Director
3. Commercial Biotechnology Separation Systems Market Analyzed in New Research Report at ReportsnReports.com
4. The Zacks Analyst Blog Highlights: SPDR Health Care Select Sector Fund, SPDR S&P 500, SPDRS&P Biotech ETF, PowerShares S&P SmallCap Health Care Portfolio and PowerShares Dynamic Biotechnology & Genome Portfolio
5. Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme
6. Sanguine BioSciences Announces Distribution Partnership with AMS Biotechnology
7. Biotech & BioPharma Professionals: CA Board of Pharmacy Executive, Virginia Herold, to Deliver Keynote at BSMA Annual Biotechnology Conference Oct 8-9
8. Biotechnology (BSMA) Conference For Supply Chain Professionals Returns To Foster City, October 8-9, 2013
9. Plant Biotechnology Companies Begin New Conversation about GMOs and How our Food is Grown
10. Nobel Laureate Dr. Oliver Smithies to Deliver Plenary Session at ISPE Biotechnology Symposium
11. TriMix for Travel Now Available at KRS Global Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... , Sept. 12, 2014 Research ... "Global Dry Film Photoresist Industry Report 2014" ... Dry Film Photoresist Industry Report 2014 is a professional ... global dry film photoresist industry . The ... definitions, classifications, applications and industry chain structure. The dry ...
(Date:9/12/2014)... -- On Thursday, September 11, 2014, the NASDAQ ... Average finished the day 0.12% lower at 17,049.00, and the ... broad based as seven out of ten sectors ended the ... ended the day at 741.83, down 0.33%, while the index ... initiated coverage on the following equities: Exelixis Inc. (NASDAQ: ...
(Date:9/11/2014)... RURO, Inc., a leading laboratory ... and sample management solutions provider, announces the release ... on the most recent version of its Limfinity® ... seen mass adoption, especially from multi-license environment customers. ... brought an entirely new User Interface and version ...
(Date:9/11/2014)... Lab researchers believes it has uncovered the secret ... layers of transition metal dichalcogenide (TMDC) materials, the ... and photonic applications. , Using two-photon excitation ... one of the most promising of 2D materials, ... dark states energy states in which single ...
Breaking Biology Technology:Global Dry Film Photoresist Industry Report 2014 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 4Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 5Limfinity® Version 5.1 Available 2Excitonic dark states shed light on TMDC atomic layers 2Excitonic dark states shed light on TMDC atomic layers 3
... Feb. 28, 2011 Idenix Pharmaceuticals, Inc. (Nasdaq: ... discovery and development of drugs for the treatment of ... the fourth quarter and year ended December 31, 2010. ... totaled $46.1 million. Business HighlightsIDX184 ...
... SAN DIEGO, Feb. 28, 2011 Verenium Corporation (Nasdaq: ... of high-performance specialty enzymes, today announced that Terminal 6, ... has successfully begun use of Verenium,s Purifine enzymatic degumming ... Argentina. Purifine enzymatic degumming is a novel process that ...
... (CTI) (Nasdaq and MTA: CTIC) announced today that it ... Conference on Thursday, March 3rd at 10:25 AM Pacific ... Center, Seattle, Washington. WBBA Life Science Innovation Northwest ConferenceCTI ... PM CETRoom 607, Washington State Conference CenterMedia Contact:Dan Eramian ...
Cached Biology Technology:Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2010 Financial Results 7World's Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Verenium's Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval 2World's Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Verenium's Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval 3World's Largest Soybean Processing Industrial Complex Converts Half of Capacity to Usage of Verenium's Purifine® PLC Enzymatic Degumming Process Engineered and Installed by Alfa Laval 4
(Date:9/12/2014)... extraction of type I collagen fibrils, in vitro as ... circular cross sections stay distributed in a range going ... of them. Jean Charvolin and Jean-Francois Sadoc from the ... therefore that, once the growth of the fibrils has ... be limited by internal physical stresses generated during the ...
(Date:9/12/2014)... strange thing happened on the way to dealing ... trillions of dollars, worth of previously unreachable oil ... environmental costs and benefits from "fracking," ... and chemicals deep into underground rock formations, are ... academic studies and government databases. The survey covers ...
(Date:9/12/2014)... Washington , September 12, 2014 ... source covering leading sectors including biometrics and mobile tech, issues ... launch of Apple Pay, its new payment service. ... founder of the Secure Identity and Biometrics Association (SIBA) and ... NXTD ) a company that is introducing its own ...
Breaking Biology News(10 mins):Conjecture on the lateral growth of Type I collagen fibrils 2Stanford-led study assesses the environmental costs and benefits of fracking 2Stanford-led study assesses the environmental costs and benefits of fracking 3Stanford-led study assesses the environmental costs and benefits of fracking 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 3Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 5
... the largest scientific conference devoted primarily to osteoporosis, will ... session focused on four key topics in nutrition and ... the MRC Epidemiology Resource Centre at the University of ... the University of Oxford, will speak on the developmental ...
... improve forecasts of dust storms in the American Southwest ... announced the finding as a five-year NASA-funded project nears ... of the University of New Mexico in Albuquerque, and ... scientists evaluated the influence of space-based observations on predictions ...
... year, some 29,000 adults and 2,000 children are diagnosed with ... abnormal production of white blood cells in the bone marrow. ... also destroys normal cells. But what if a way could ... A team of Syracuse University researchers believes it may have ...
Cached Biology News:Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok 2NASA-enhanced dust storm predictions to aid health community 2NASA-enhanced dust storm predictions to aid health community 3Syracuse University researchers discover new way to attack some forms of leukemia 2Syracuse University researchers discover new way to attack some forms of leukemia 3
... expression of an N-terminal FLAG® fusion and ... marker from bicistronic mRNA. Two genes ... for transcription of a single message from ... for protein-protein interaction studies, multi-subunit proteins, and ...
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: